Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDWhitehawk Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2025 | 1 | $0.83 | $0.83 | $0.83 |
| Q3 2025 | 1 | $0.03 | $0.10 | $0.07 |
| Q4 2025 | 1 | -$1.11 | -$0.27 | -$0.69 |
| Q1 2026 | 1 | -$0.34 | -$0.34 | -$0.34 |
| Q2 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2026 | 1 | -$0.33 | -$0.33 | -$0.33 |
| Q4 2026 | 1 | -$0.35 | -$0.35 | -$0.35 |
Whitehawk Therapeutics Inc Earnings Date And Information
Whitehawk Therapeutics Inc last posted its earnings results on Thursday, November 6th, 2025. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.51 by $0.25. The company had revenue of 0 for the quarter and had revenue of 25.98 M for the year. Whitehawk Therapeutics Inc has generated $-2 earnings per share over the last year ($-2.36 diluted earnings per share) and currently has a price-to-earnings ratio of -16.98. Whitehawk Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 12th, 2026 based on prior year's report dates.
Whitehawk Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2025 | Q3 2025 | N/A | -$0.26 | N/A | $33.33 M | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$0.76 | N/A | $50.00 M | $0 |
| 03/31/2025 | Q1 2025 | N/A | $1.84 | N/A | $7.55 M | $7.15 M |
| 12/31/2024 | Q4 2024 | N/A | -$0.67 | N/A | N/A | $7.24 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.46 | N/A | $6.59 M | $7.21 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.54 | N/A | $6.19 M | $6.18 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.68 | N/A | N/A | $5.35 M |
| 12/31/2023 | Q4 2023 | N/A | -$0.60 | N/A | N/A | $6.33 M |
| 09/30/2023 | Q3 2023 | N/A | -$0.60 | N/A | $6.62 M | $5.96 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.67 | N/A | N/A | $6.20 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.57 | N/A | N/A | $5.87 M |
| 12/31/2022 | Q4 2022 | N/A | -$0.52 | N/A | N/A | $5.23 M |
| 09/30/2022 | Q3 2022 | N/A | -$0.68 | N/A | N/A | $4.25 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.87 | N/A | N/A | $3.44 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.66 | N/A | N/A | $2.31 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.77 | N/A | N/A | $1.00 M |
| 09/30/2021 | Q3 2021 | N/A | -$4.17 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.07 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.26 | N/A | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | $0.38 | N/A | N/A | $14.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Whitehawk Therapeutics Inc Earnings: FAQ's
Whitehawk Therapeutics Inc has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 12th, 2026 based offlast year's report dates.
In the previous quarter, Whitehawk Therapeutics Inc (:WHWK) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.51 by $0.25.
The conference call for Whitehawk Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Whitehawk Therapeutics Inc's latest earnings report can be read online.
Whitehawk Therapeutics Inc (:WHWK) has a recorded annual revenue of $25.98 M.
Whitehawk Therapeutics Inc (:WHWK) has a recorded net income of $-63,691,000.Whitehawk Therapeutics Inc has generated $-2.36 earnings per share over the last four quarters.
Whitehawk Therapeutics Inc (:WHWK) has a price-to-earnings ratio of -16.98 and price/earnings-to-growth ratio is 0.13.